ORCHARD THERAPEUTICS PLC's ticker is ORTX and the CUSIP is 68570P101. A total of 48 filers reported holding ORCHARD THERAPEUTICS PLC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $360,000 | +35.3% | 616,402 | +64.7% | 0.05% | +50.0% |
| Q1 2022 | $266,000 | -40.5% | 374,276 | +10.5% | 0.04% | -35.7% |
| Q4 2021 | $447,000 | -48.1% | 338,756 | -9.6% | 0.06% | -36.4% |
| Q3 2021 | $862,000 | -57.1% | 374,811 | +35.6% | 0.09% | -73.6% |
| Q1 2021 | $2,007,000 | +4263.0% | 276,381 | +2484.0% | 0.33% | +4062.5% |
| Q4 2020 | $46,000 | -2.1% | 10,696 | -5.7% | 0.01% | 0.0% |
| Q3 2020 | $47,000 | -62.1% | 11,347 | -45.2% | 0.01% | -88.4% |
| Q2 2020 | $124,000 | – | 20,707 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CHI Advisors LLC | 5,307,751 | $3,101,000 | 1.18% |
| TANG CAPITAL MANAGEMENT LLC | 2,000,000 | $1,168,000 | 0.18% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 6,949,416 | $4,060,000 | 0.08% |
| Artal Group S.A. | 1,803,858 | $1,054,000 | 0.06% |
| GSA CAPITAL PARTNERS LLP | 616,402 | $360,000 | 0.05% |
| RA Capital Management | 3,040,885 | $1,776,000 | 0.05% |
| Forefront Analytics, LLC | 92,641 | $58,000 | 0.03% |
| Temasek Holdings (Private) Ltd | 4,319,049 | $2,523,188 | 0.01% |
| FEDERATED HERMES, INC. | 8,309,859 | $4,853,000 | 0.01% |
| Cormorant Asset Management, LP | 256,649 | $150,000 | 0.01% |